ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625516; 2) Community: the network communities that were significantly associated with the response to NSC 625516; 3) Molecule: the relationships between components within communities and NSC 625516; 4) MDR: the compounds that were significantly associated with the NSC 625516.

NSC Compound Enrichment Correlation
NSC 724599 S-(diisopropylarsino)-3-mercapto-1,2-propanediol 0.0385067071027343 0.32928116
NSC 73735 B 3845 0.0385067071027343 0.44706356
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0385067071027343 0.34323414
NSC 749862 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0385067071027343 0.27178611
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.0385067071027343 0.44661887
NSC 760181 9-(3-fluorobenzyl)-7-(3-fluorobenzyloxy)-2-(4-fluorobenzyl)-1-methyl-9H-beta-carbolinium bromide 0.0385067071027343 0.49192424
NSC 93135 OXYACANTHINE 0.0385067071027343 0.37548009
NSC 112758 Rubomycin 0.0385067071027345 0.25176303
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0385067071027345 0.2465108
NSC 1390 Allopurinol 0.0385067071027345 0.19445338
Total:147  Current:117    [First] [Prev] [Next] [Last]